Idiopathic Pulmonary Fibrosis Clinical Trials

A listing of Idiopathic Pulmonary Fibrosis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 114 clinical trials
featured
Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

  • 2074 views
  • 08 Nov, 2020
  • 1 location
featured
Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis

Background: Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease that becomes worse over time. There is currently no effective treatment for it. Researchers

chest x-ray
walk tests
idiopathic pulmonary fibrosis
chest ct
x-rays
  • 162 views
  • 23 Nov, 2020
  • 1 location
featured
A 24-week, double-blind, randomized, parallel-group study evaluating the efficacy and safety of oral nintedanib coadministered with oral sildenafil, compared to treatment with nintedanib alone, in patients with idiopathic pulmonary fibrosis (IPF) and advanced lung function impairment

patients with idiopathic pulmonary fibrosis (IPF) and advanced lung function impairment

  • 1316 views
  • 23 Nov, 2020
  • 1 location
A Trial to Assess the Safety Immunogenicity and Efficacy of a Trivalent Rotavirus P2-VP8 Subunit Vaccine in Prevention of Severe Rotavirus Gastroenteritis in Healthy Infants in Africa and India

of Rotarix/placebo PO at monthly intervals starting at 6 to <8 weeks of age, administered concomitantly with EPI/UIP vaccines. To maintain the blind, infants allocated to the TV P2-VP8 vaccine arm

  • 0 views
  • 11 Apr, 2021
  • 1 location
Management of Progressive Disease in Idiopathic Pulmonary Fibrosis

Idiopathic pulmonary fibrosis (IPF) is a prototype of chronic, progressive, and fibrotic lung disease. It has been considered rare, with an incidence estimated to 11.5 cases per 100 000

  • 0 views
  • 26 Jan, 2021
  • 1 location
Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

Pulmonary Fibrosis

pamrevlumab
idiopathic pulmonary fibrosis
pirfenidone
nintedanib
diffusion capacity of the lung for carbon monoxide
  • 0 views
  • 03 Feb, 2021
  • 10 locations
A Study to Test the Efficacy and Safety of Inhaled TD139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

This is a randomized, double-blind, placebo-controlled phase 2b trial in subjects with IPF (idiopathic pulmonary fibrosis) investigating the efficacy and safety of TD139.

forced vital capacity
idiopathic pulmonary fibrosis
pirfenidone
nintedanib
diffusion capacity of the lung for carbon monoxide
  • 384 views
  • 15 Feb, 2021
  • 132 locations
Safety Efficacy and Pharmacokinetics of C21 in Subjects With IPF

This trial is a multi-centre, open-label, single-arm phase 2 trial investigating the safety, efficacy and pharmacokinetics of C21 in subjects with idiopathic pulmonary fibrosis.

  • 0 views
  • 04 Apr, 2021
  • 20 locations
A Study to Test How Taking BI 1015550 for 12 Weeks Affects Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

This study is open to adults with idiopathic pulmonary fibrosis (IPF) who are at least 40 years old. People taking standard medicines for IPF, including antifibrotic medicines, can continue

lung biopsy
nintedanib
diffusion capacity of the lung for carbon monoxide
pulmonary function test
forced vital capacity
  • 0 views
  • 11 Apr, 2021
  • 58 locations
High Intensity Interval Training in Fibrotic Interstitial Lung Disease

The fibrotic interstitial lung diseases (fILD) is a group of debilitating chronic lung conditions that are characterised by scarring of lung tissue, dyspnoea on exertion and significant physical impairment. Exercise training is recommended for people with fILD in improving breathlessness and exercise tolerance. However, despite the best efforts of patients …

  • 7 views
  • 09 Mar, 2021
  • 4 locations